$101.20
0.09% yesterday
Nasdaq, Dec 01, 10:00 pm CET
ISIN
US30063P1057
Symbol
EXAS

Exact Sciences Corporation Stock price

$101.20
+34.22 51.09% 1M
+45.07 80.30% 6M
+45.01 80.10% YTD
+39.51 64.05% 1Y
+55.20 120.00% 3Y
-22.03 17.88% 5Y
+92.09 1,010.87% 10Y
+99.76 6,927.78% 20Y
Nasdaq, Closing price Mon, Dec 01 2025
-0.09 0.09%
ISIN
US30063P1057
Symbol
EXAS
Industry

New AI Insights on Exact Sciences Corporation Insights AI Insights on Exact Sciences Corporation

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$19.2b
Enterprise Value
$20.5b
Net debt
$1.3b
Cash
$1.0b
Shares outstanding
189.5m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
6.2 | 6.0
EV/Sales
6.7 | 6.4
EV/FCF
83.1
P/B
7.7
Financial Health
Equity Ratio
40.5%
Return on Equity
-42.8%
ROCE
-2.9%
ROIC
-3.2%
Debt/Equity
0.9
Financials (TTM | estimate)
Revenue
$3.1b | $3.2b
EBITDA
$63.3m | $467.2m
EBIT
$-155.1m | $-110.7m
Net Income
$-986.6m | $-122.2m
Free Cash Flow
$247.1m
Growth (TTM | estimate)
Revenue
14.5% | 16.7%
EBITDA
155.3% | 377.8%
EBIT
25.8% | 38.2%
Net Income
-360.9% | 88.1%
Free Cash Flow
366.8%
Margin (TTM | estimate)
Gross
67.4%
EBITDA
2.1% | 14.5%
EBIT
-5.0%
Net
-32.0% | -3.8%
Free Cash Flow
8.0%
More
EPS
$-5.2
FCF per Share
$1.3
Short interest
4.4%
Employees
7k
Rev per Employee
$400.0k
Show more

Is Exact Sciences Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,075 stocks worldwide.

Exact Sciences Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

30 Analysts have issued a Exact Sciences Corporation forecast:

26x Buy
87%
4x Hold
13%

Analyst Opinions

30 Analysts have issued a Exact Sciences Corporation forecast:

Buy
87%
Hold
13%

Financial data from Exact Sciences Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
3,082 3,082
14% 14%
100%
- Direct Costs 1,006 1,006
38% 38%
33%
2,076 2,076
6% 6%
67%
- Selling and Administrative Expenses 1,803 1,803
10% 10%
58%
- Research and Development Expense 431 431
3% 3%
14%
63 63
155% 155%
2%
- Depreciation and Amortization 218 218
131% 131%
7%
EBIT (Operating Income) EBIT -155 -155
26% 26%
-5%
Net Profit -987 -987
361% 361%
-32%

In millions USD.

Don't miss a Thing! We will send you all news about Exact Sciences Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Exact Sciences Corporation Stock News

Neutral
Business Wire
8 days ago
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, will present 10 abstracts across its Precision Oncology portfolio at the 2025 San Antonio Breast Cancer Symposium (SABCS), taking place from December 9-12 in San Antonio, Texas. The data to be presented builds upon Exact Sciences' long-standing commitment to backing ...
Neutral
GlobeNewsWire
8 days ago
MONSEY, N.Y., Nov. 24, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Exact Sciences Corporation (Nasdaq: EXAS) (“Exact Sciences”) to Abbott Laboratories for $105.00 per share in cash.
Neutral
24/7 Wall Street
8 days ago
The shortened holiday week is here, and the futures are trading higher this morning.
More Exact Sciences Corporation News

Company Profile

EXACT Sciences Corp. is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI.

Head office United States
CEO Kevin Conroy
Employees 6,950
Founded 1995
Website www.exactsciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today